Send feedback

CAVIN2 p.Lys173=

c.519A>G · rs61742216 · VCV782418

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Common
common (popmax 7.97%, afr) — too common for a highly-penetrant pathogenic allele

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.82GERP -3.3, phastCons 0.011
Overall
CADD3.254PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 7.97% African / African-American · 5,981/75,002 alleles
Filtering AF 7.81% ClinGen BA1/BS1 input FAF95, joint · FAF99 7.74%
Overall 0.42% 6,770/1,613,768 alleles · common
Ancestry group Frequency 1 in
African / African-Americangrpmax 7.97% 13
Remaining individualsnot grpmax-eligible 0.546% 183
Admixed American 0.452% 221
Middle Eastern 0.248% 404
South Asian 0.0165% 6,071
European (non-Finnish) 0.0125% 8,026

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CAVIN2
Protein
p.Lys173=
Coding
c.519A>G
MANE Select
NM_004657
dbSNP
rs61742216
Type
single nucleotide variant
Location
chr2:191836682 (GRCh38)
Gene constraint
LOEUF 1.593 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 63.48
Full CAVIN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cavin2-p-lys173 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown